Search research articles
Contact Us
Filters
Showing results (1-10 of 62) with videos related to
Page
of 7
Sort By:
Current Pharmaceutical Design
|
August 13, 2002
Monoclonal antibody-based therapy strategies: providing options for the cancer patient
Diane E Milenic
Cancer Biology & Therapy
|
February 21, 2004
Targeting of radio-isotopes for cancer therapy
Diane E Milenic, Martin W Brechbiel
Discovery Medicine
|
August 14, 2010
Antibody guided precision radiation therapy
Erik D Brady, Diane E Milenic, Martin W Brechbiel
Nature Reviews. Drug Discovery
|
June 3, 2004
Antibody-targeted radiation cancer therapy
Diane E Milenic, Erik D Brady, Martin W Brechbiel
Nuclear Medicine and Biology
|
April 23, 2013
Methodology for labeling proteins and peptides with lead-212 (212Pb)
Kwamena E Baidoo, Diane E Milenic, Martin W Brechbiel
Pharmaceuticals (Basel, Switzerland)
|
August 1, 2015
Bench to Bedside: Stability Studies of GMP Produced Trastuzumab-TCMC in Support of a Clinical Trial
Diane E Milenic, Kwamena E Baidoo, Martin W Brechbiel
Bioconjugate Chemistry
|
November 16, 2010
Improved speciation characteristics of PEGylated indocyanine green-labeled Panitumumab: revisiting the solution and spectroscopic properties of a near-infrared emitting anti-HER1 antibody for optical imaging of cancer
Aaron Joseph L Villaraza, Diane E Milenic, Martin W Brechbiel
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 4, 2012
PET and MRI of metastatic peritoneal and pulmonary colorectal cancer in mice with human epidermal growth factor receptor 1-targeted 89Zr-labeled panitumumab
Tapan K Nayak, Kayhan Garmestani, Diane E Milenic, et al.
Nuclear Medicine and Biology
|
June 29, 2002
A new and convenient method for purification of 86Y using a Sr(II) selective resin and comparison of biodistribution of 86Y and 111In labeled Herceptin
Kayhan Garmestani, Diane E Milenic, Paul S Plascjak, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 4, 2012
Sensitization of tumor to ²¹²Pb radioimmunotherapy by gemcitabine involves initial abrogation of G2 arrest and blocked DNA damage repair by interference with Rad51
Kwon Joong Yong, Diane E Milenic, Kwamena E Baidoo, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 62) with videos related to
Sort By:
Page
of 7
Current Pharmaceutical Design
|
August 13, 2002
Monoclonal antibody-based therapy strategies: providing options for the cancer patient
Diane E Milenic
Cancer Biology & Therapy
|
February 21, 2004
Targeting of radio-isotopes for cancer therapy
Diane E Milenic, Martin W Brechbiel
Discovery Medicine
|
August 14, 2010
Antibody guided precision radiation therapy
Erik D Brady, Diane E Milenic, Martin W Brechbiel
Nature Reviews. Drug Discovery
|
June 3, 2004
Antibody-targeted radiation cancer therapy
Diane E Milenic, Erik D Brady, Martin W Brechbiel
Nuclear Medicine and Biology
|
April 23, 2013
Methodology for labeling proteins and peptides with lead-212 (212Pb)
Kwamena E Baidoo, Diane E Milenic, Martin W Brechbiel
Pharmaceuticals (Basel, Switzerland)
|
August 1, 2015
Bench to Bedside: Stability Studies of GMP Produced Trastuzumab-TCMC in Support of a Clinical Trial
Diane E Milenic, Kwamena E Baidoo, Martin W Brechbiel
Bioconjugate Chemistry
|
November 16, 2010
Improved speciation characteristics of PEGylated indocyanine green-labeled Panitumumab: revisiting the solution and spectroscopic properties of a near-infrared emitting anti-HER1 antibody for optical imaging of cancer
Aaron Joseph L Villaraza, Diane E Milenic, Martin W Brechbiel
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 4, 2012
PET and MRI of metastatic peritoneal and pulmonary colorectal cancer in mice with human epidermal growth factor receptor 1-targeted 89Zr-labeled panitumumab
Tapan K Nayak, Kayhan Garmestani, Diane E Milenic, et al.
Nuclear Medicine and Biology
|
June 29, 2002
A new and convenient method for purification of 86Y using a Sr(II) selective resin and comparison of biodistribution of 86Y and 111In labeled Herceptin
Kayhan Garmestani, Diane E Milenic, Paul S Plascjak, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 4, 2012
Sensitization of tumor to ²¹²Pb radioimmunotherapy by gemcitabine involves initial abrogation of G2 arrest and blocked DNA damage repair by interference with Rad51
Kwon Joong Yong, Diane E Milenic, Kwamena E Baidoo, et al.
Page
of 7